The featured snippet answers what they are
Participants Experience with GLP-1 Medications For analysis below, we group participants with personal GLP-1 experience (those who either currently or have previously taken GLP-1 medications, n=204) and those without (n=819)
Non-peptidic oral GLP-1RAs may eventually reduce supply pressures because they do not require peptide synthesis or cold-chain storage, but this will depend on scalable, cost-efficient manufacturing pathways
But if it is already 11 hours or more since missing a dosage, it is unsafe to take the missed dose after such a long delay
Zhang HS, Li HY, Zhou Y, Wu MR, Zhou HS
Are these improvements simply the result of weight loss, or do GLP-1 medications have direct anti-inflammatory and neuromodulatory effects